Trademark Overview
On Wednesday, June 4, 2025, a trademark application was filed for COREMETABOLOMICS BY NIGHTINGALE HEALTH with the United States Patent and Trademark Office. The USPTO has given the COREMETABOLOMICS BY NIGHTINGALE HEALTH trademark a serial number of 79434173. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 30, 2026. This trademark is owned by Nightingale Health Oyj. The COREMETABOLOMICS BY NIGHTINGALE HEALTH trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical research; scientific laboratory services; medical research laboratory services; biomedical research services; blood analysis services for scientific research purposes; biofluid analysis services; biofluid analysis services for scientific research purposes; provision of online non-downloadable web-based software applications for collecting, measuring, analysing, monitoring and reporting health condition data as well as physiological and biosignal data; consultancy relating to scientific laboratory testing; rental of laboratory apparatus and instruments; information, consultancy and advisory services relating to medical research, and blood and biofluid analysis for scientific research purposes
Medical laboratory analysis services relating to the treatment of persons; medical blood test services; medical laboratory services for the analysis of blood and biofluid samples taken from patients; conducting medical screenings for disease risk factors; collection and preservation of human blood; providing medical information; preparation of medical reports relating to health care and wellbeing, namely, providing medical information to patients in the form of reports in the field of physical wellbeing; providing medical information and health and bodily wellbeing information to patients, consumers, and medical professionals by means of preparation of reports relating to health care matters; information, advisory and consultancy services relating to medical laboratory analysis services relating to the treatment of persons, blood and biofluid analysis services for diagnostic purposes provided by medical laboratories, and the provision of medical information